Case Report

Thrombotic Microangiopathy as a Complication of Medicinal Leech Therapy

Authors: Jalal Etemadi, MD, Mohammad R. Ardalan, MD, Roza Motavali, MD, R Shane Tubbs, PhD, Mohammadali M. Shoja, MD

Abstract

Medicinal leeches (hirudo medicinalis) are increasingly used as a useful therapeutic option in various medical and surgical settings. The potential complications associated with this therapy include infections with Aeromonas species, bleeding, anemia, and allergic reactions. We describe a patient who developed thrombotic microangiopathy and acute renal failure following leech therapy. It is proposed that the series of nonhuman proteins within leech saliva may be capable of injuring the endothelium.


Key Points


* Medicinal leeches are used in many medical and surgical settings.


* The complications of medicinal leech therapy are infections with Aeromonas species, bleeding, anemia, and allergic reactions.


* Clinicians should also consider thrombotic microangiopathy and renal failure as potential complications of this emerging therapy.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1.Ardalan MR. Review of thrombotic microangiopathy (TMA) and post-renal Transplant TMA. Saudi J Kidney Dis Transpl 2006;17:235–244.
 
2.Whitaker IS, Rao J, Izadi D, et al. Hirido medicinalis: ancient origins, and trends in the use of medicinal leeches throughout history. Br J Oral Maxillofac Surg 2004;42:133–137.
 
3.Rados C. Beyond Bloodletting: FDA Gives Leeches a Medical Makeover. Available at: http://www.fda.gov/fdac/features/2004/504_leech.html. Accessed April 28, 2008.
 
4.Daane S, Zamora S, Rockwell WB. Clinical use of leeches in reconstructive surgery. Am J Orthop 1997;26:528–532.
 
5.Michalsen A, Klotz S, Ludtke R, et al. Effectiveness of leech therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med 2003;139:724–730.
 
6.Smeets IMG, Engelberts I. The use of leeches in a case of post-operative life-threatening macroglossia. J Laryngol Otol 1995;109:442–444.
 
7.Grossman MD, Karlovitz A. Lingual trauma: the use of medicinal leeches in the treatment of massive lingual hematoma. J Trauma 1998;44:1083–1085.
 
8.Soucacos PN, Beris AE, Malizos KN, et al. The use of medicinal leeches, Hirudo medicinalis, to restore venous circulation in trauma and reconstructive microsurgery. Int Angiol 1994;13:251–258.
 
9.Snower DP, Ruef C, Kuritza AP, et al. Aeromonas hydrophilia infection associated with the use of medicinal leeches. J Clin Microbiol 1989;27:1421–1422.
 
10.Whitaker IS, Cheung CK, Chahal CA, et al. By what mechanism do leeches help to salvage ischemic tissues? Br J Oral Maxillofac Surg 2005;43:155–160.
 
11.Isbister GK, Little M, Cull G, et al. Thrombotic microangiopathy from Australian brown snake (Pseudonaja) envenoming. Intern Med J 2007;37:523–528.
 
12.Schneemann M, Cathomas R, Laidlow ST, et al. Life-threatening envenoming by the Saharam horned viper (Cerastes cerastes) causing micro-angiopathic haemolysis, coagulopathy and acute renal failure: clinical case and review. QJM 2004;97:717–727.